Premal is Co-Founder & President at Ciitizen, a leading digital health company working to empower patients with their own health data. There, he oversees all operations and supports development of company strategies, including go-to-market strategies. Prior to Ciitizen, Premal was CEO of Applied Proteomics, a mass spectrometry-based proteomics company that launched a blood-based colorectal cancer diagnostic test. Before that, he led corporate development efforts at Genomic Heath (now part of Exact Sciences). Premal started his career as a management consultant at Booz & Company assisting clients in front-office strategies. He is a scientist by training, having published several papers in the field of computational biology while at the California Institute of Technology.
Patients and their caregivers - particularly in the case of patients who with serious or life-threatening illnesses - are tired of waiting on the sidelines for research to come to them (for example, to find them for clinical trials or to address questions of importance to patients). Increasingly patients are seizing greater opportunities to have access to their health information (including genomic/genetic data and clinical data from electronic medical records, including images) to contribute this data directly to research initiatives that they trust and that are addressing questions of importance to them (either because they could benefit individually or the research is focused on questions the patient believes are important). This panel will showcase existing initiatives that are putting patients (and patient groups) more in the driver’s seat with respect to precision medicine.